amiodarone has been researched along with Heart Disease, Ischemic in 76 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this double-blind, placebo-controlled trial, we randomly assigned 665 patients who were receiving anticoagulants and had persistent atrial fibrillation to receive amiodarone (267 patients), sotalol (261 patients), or placebo (137 patients) and monitored them for 1 to 4." | 9.11 | Amiodarone versus sotalol for atrial fibrillation. ( Atwood, JE; Ezekowitz, MD; Fletcher, RD; Harris, CL; Jacobson, AK; Lewis, HD; Lopez, B; Raisch, DW; Reda, DJ; Sharma, SC; Singh, BN; Singh, SN; Tang, XC, 2005) |
| "In the present manuscript we critically review the available evidence for pleiotropic effects of dronedarone in settings of myocardial and cerebral ischemia/reperfusion, both from experimental and clinical data." | 8.88 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. ( Heusch, G; Schulz, R, 2012) |
| "To compare the early postarrest inflammatory cytokine response between animals administered amiodarone (AMIO) and lidocaine (LIDO) intra-arrest during resuscitation from ventricular fibrillation (VF)." | 7.79 | Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. ( Niemann, JT; Rosborough, JP; Shah, AP; Thomas, JL; Youngquist, ST, 2013) |
| "We studied inotropic reaction of isolated myocardium of patients with heart failure induced by ischemic and rheumatic cardiac involvement after periods of rest at the background of amiodarone." | 7.74 | [Comparative assessment of inotropic reaction of isolated myocardium of patients with ischemic and rheumatic heart disease after short-term periods of rest at the background of amiodarone]. ( Afanas'ev, SA; Evtushenko, AV; Kondrat'eva, DS; Popov, SV; Shipulin, VM, 2008) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 7.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 7.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| "Amiodarone treatment was associated with a significant increase in TNF-alpha levels in patients with ischemic cardiomyopathy, 12." | 6.69 | Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Fay, WP; Fisher, SG; Fletcher, RD; Morady, F; Oral, H; Singh, SN, 1999) |
| " Long-term administration of daily low doses of AD carries the risk of progression to irreversible liver injury." | 5.33 | Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. ( Kotani, K; Maesawa, C; Masuda, T; Oikawa, H; Oikawa, K; Ono, S; Oriso, S; Sato, R; Suzuki, K; Yamada, H; Yashima-Abo, A, 2005) |
| "Dronedarone was given in Wistar rats (90 mg/kg, once daily (od) for 2 weeks) (DRON), while untreated animals served as controls (CONT)." | 5.33 | Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. ( Cokkinos, DV; Malliopoulou, V; Moraitis, P; Mourouzis, I; Paizis, I; Pantos, C; Sfakianoudis, K; Tzeis, S; Varonos, DD, 2005) |
| "In this double-blind, placebo-controlled trial, we randomly assigned 665 patients who were receiving anticoagulants and had persistent atrial fibrillation to receive amiodarone (267 patients), sotalol (261 patients), or placebo (137 patients) and monitored them for 1 to 4." | 5.11 | Amiodarone versus sotalol for atrial fibrillation. ( Atwood, JE; Ezekowitz, MD; Fletcher, RD; Harris, CL; Jacobson, AK; Lewis, HD; Lopez, B; Raisch, DW; Reda, DJ; Sharma, SC; Singh, BN; Singh, SN; Tang, XC, 2005) |
| "In the present manuscript we critically review the available evidence for pleiotropic effects of dronedarone in settings of myocardial and cerebral ischemia/reperfusion, both from experimental and clinical data." | 4.88 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. ( Heusch, G; Schulz, R, 2012) |
| "We enrolled all consecutive patients with unsuccessful/not feasible catheter ablation and ineffective/contraindicated amiodarone or beta-blockers, which started the mexiletine treatment for refractory ventricular tachycardia (VT) or ventricular fibrillation (VF) between January 2010 and January 2020." | 4.12 | Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study. ( Bilato, C; Cavedon, S; Mecenero, A; Mugnai, G; Paolini, C; Perrone, C, 2022) |
| "To compare the early postarrest inflammatory cytokine response between animals administered amiodarone (AMIO) and lidocaine (LIDO) intra-arrest during resuscitation from ventricular fibrillation (VF)." | 3.79 | Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. ( Niemann, JT; Rosborough, JP; Shah, AP; Thomas, JL; Youngquist, ST, 2013) |
| "We studied inotropic reaction of isolated myocardium of patients with heart failure induced by ischemic and rheumatic cardiac involvement after periods of rest at the background of amiodarone." | 3.74 | [Comparative assessment of inotropic reaction of isolated myocardium of patients with ischemic and rheumatic heart disease after short-term periods of rest at the background of amiodarone]. ( Afanas'ev, SA; Evtushenko, AV; Kondrat'eva, DS; Popov, SV; Shipulin, VM, 2008) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) investigated the effects of amiodarone versus placebo in patients after myocardial infarction who had left ventricular ejection fraction | 3.73 | Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). ( Badilini, F; Benchetrit, C; Coumel, P; Leenhardt, A; Maisonblanche, P; Milliez, P; Siliste, C; Vicaut, E, 2005) |
| "Experimental studies have described an increase in ventricular fibrillation threshold (VFT) by intravenous amiodarone." | 3.72 | Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. ( Anastasiou-Nana, MI; Charitos, CE; Doufas, A; Drakos, SG; Mavrikakis, EM; Nanas, JN; Ntalianis, A; Siafakas, CX; Terrovitis, JV; Tsagalou, EP, 2004) |
| " Finally, prophylactic amiodarone significantly reduced postoperative arrhythmias (p = 0." | 3.72 | Several new considerations in mitral valve repair. ( Addai, TR; Glower, DD; Orozco, RE; Rankin, JS; Rodgers, TL; Shaw, LK; Tuttle, RH, 2004) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 3.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "The effect of oral amiodarone (AMD) therapy on left ventricular (LV) function was evaluated retrospectively in Japanese patients with ventricular tachyarrhythmias and congestive heart failure." | 3.70 | Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias. ( Yamada, S; Yamaguchi, I, 1998) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 3.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| " The patient was discharged with digitalis, nitrates, aspirin and amiodarone for prophylactic treatment of paroxystic atrial fibrillation." | 3.68 | [Ventricular fibrillation during stress test on a treadmill. Apropos of a case]. ( Baroffio, R; Croce, A; Tisi, G, 1993) |
| "Two patients with coronary heart disease and previous myocardial infarction, treated with amiodarone for severe ventricular arrhythmias, developed pulmonary toxicity." | 3.68 | [Pulmonary toxicity due to amiodarone]. ( Ferrari, G; Galli, M; Politi, A, 1993) |
| "In patients with ischemic heart disease and ventricular tachycardia (VT) refractory to high dose amiodarone, the two most common therapeutic options are adjunctive mexiletine therapy or catheter ablation." | 2.87 | Mexiletine or catheter ablation after amiodarone failure in the VANISH trial. ( Deyell, MW; Doucette, S; Essebag, V; Gardner, M; Gray, C; Healey, JS; Hruczkowski, T; Leong-Sit, P; Nault, I; Nery, PB; Parkash, R; Rivard, L; Sapp, JL; Steinberg, C; Sterns, LD, 2018) |
| "The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely." | 2.73 | Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. ( Anderson, J; Bardy, GH; Hellkamp, AS; Johnson, G; Lee, KL; Mark, DB; Olshansky, B; Packer, D; Poole, JE, 2008) |
| "Four patients with interstitial lung disease who were treated by amiodarone for ischemic heart diseases were evaluated by a conventional clinical workup." | 2.73 | The role of induced sputum in amiodarone-associated interstitial lung diseases. ( Fireman, E; Priel, IE; Topilsky, I; Viskin, S, 2007) |
| "Amiodarone treatment was associated with a significant increase in TNF-alpha levels in patients with ischemic cardiomyopathy, 12." | 2.69 | Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Fay, WP; Fisher, SG; Fletcher, RD; Morady, F; Oral, H; Singh, SN, 1999) |
| "Amiodarone has a more favourable therapeutic profile than flecainide and propafenone in these patients, having less tendency to worsen heart failure." | 2.67 | A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). ( , 1992) |
| "Incessant ventricular tachycardia and "electrical storms" are emergencies, requiring urgent action in a close cooperation between critical care physicians and cardiologists." | 2.48 | [Incessant or recurrent ventricular tachycardia. Indications for emergency ablation]. ( Figulla, HR; Kühnert, H; Prochnau, D; Surber, R, 2012) |
| "Acute myocardial infarction was induced in mice (AMI), while sham operated animals served as controls (SHAM)." | 1.39 | Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice. ( Galanopoulos, G; Kostakou, E; Mantzouratou, P; Mourouzis, I; Pantos, C, 2013) |
| "Eleven (92%) were male, and 10 (83%) had ischemic heart disease with an average ejection fraction of 0." | 1.37 | Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. ( Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP, 2011) |
| "Dronedarone was given in Wistar rats (90 mg/kg, once daily (od) for 2 weeks) (DRON), while untreated animals served as controls (CONT)." | 1.33 | Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. ( Cokkinos, DV; Malliopoulou, V; Moraitis, P; Mourouzis, I; Paizis, I; Pantos, C; Sfakianoudis, K; Tzeis, S; Varonos, DD, 2005) |
| " Long-term administration of daily low doses of AD carries the risk of progression to irreversible liver injury." | 1.33 | Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. ( Kotani, K; Maesawa, C; Masuda, T; Oikawa, H; Oikawa, K; Ono, S; Oriso, S; Sato, R; Suzuki, K; Yamada, H; Yashima-Abo, A, 2005) |
| "Amiodarone is a widely used and potent antiarrhythmic agent that is metabolized to desethylamiodarone." | 1.32 | Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. ( Bognar, Z; Gallyas, F; Sumegi, B; Tapodi, A; Toth, A; Varbiro, G; Veres, B, 2003) |
| "In patients with ischemic heart disease, recurrences of VT or VF peaked in the morning." | 1.31 | Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators. ( Aizawa, Y; Taneda, K, 2001) |
| "A 71-year-old man who had ischemic heart disease with poor left ventricular function and ventricular tachycardia was admitted to hospital for evaluation." | 1.30 | [Effective low-dose amiodarone therapy for ventricular tachycardia complicated with ischemic heart disease and poor left ventricular function in an elderly patient]. ( Abe, M; Hayashi, Y; Joh, T; Kazatani, Y; Kikuchi, S; Kubo, M; Makita, M; Matsunaka, T; Tatsuno, H, 1997) |
| "Amiodarone treatment maintained the aortic flow at a significantly higher value; the duration of severe arrhythmias was significantly decreased by the drug." | 1.30 | Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion. ( Clauw, F; Demaison, L; Grynberg, A; Martine, L; Moreau, D; Rochette, L, 1999) |
| "It is stated that CHD patients with arrhythmia develop latent hypothyrosis of T3-low-syndrome type." | 1.29 | [The effect of kordaron on thyroid function in patients with ischemic heart disease]. ( Tereshchenko, IV; Tsepelev, VV, 1995) |
| "Amiodarone is a potent phospholipase inhibitor, but its potential or that of any other inhibitor to simultaneously attenuate lipid abnormalities and electrophysiological changes in the very early phase of ischemia has never been studied." | 1.29 | Phospholipase inhibition and the electrophysiology of acute ischemia: studies with amiodarone. ( Harris, L; Kimura, Y; Shaikh, NA, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 28 (36.84) | 18.2507 |
| 2000's | 32 (42.11) | 29.6817 |
| 2010's | 13 (17.11) | 24.3611 |
| 2020's | 3 (3.95) | 2.80 |
| Authors | Studies |
|---|---|
| Plouvier, B | 1 |
| Beatch, GN | 1 |
| Jung, GL | 1 |
| Zolotoy, A | 1 |
| Sheng, T | 1 |
| Clohs, L | 1 |
| Barrett, TD | 1 |
| Fedida, D | 1 |
| Wang, WQ | 1 |
| Zhu, JJ | 1 |
| Liu, Y | 1 |
| Abraham, S | 1 |
| Lynn, L | 1 |
| Dong, Y | 1 |
| Wall, RA | 1 |
| Walker, MJ | 1 |
| Ceccarelli, SM | 1 |
| Chomienne, O | 1 |
| Gubler, M | 1 |
| Arduini, A | 1 |
| Arenal, Á | 1 |
| Ávila, P | 1 |
| Jiménez-Candil, J | 1 |
| Tercedor, L | 1 |
| Calvo, D | 1 |
| Arribas, F | 1 |
| Fernández-Portales, J | 1 |
| Merino, JL | 1 |
| Hernández-Madrid, A | 1 |
| Fernández-Avilés, FJ | 1 |
| Berruezo, A | 1 |
| Di Biase, L | 1 |
| Romero, J | 1 |
| Du, X | 1 |
| Mohanty, S | 1 |
| Trivedi, C | 1 |
| Della Rocca, DG | 1 |
| Patel, K | 1 |
| Sanchez, J | 1 |
| Yang, R | 1 |
| Alviz, I | 1 |
| Mohanty, P | 1 |
| Gianni, C | 1 |
| Tarantino, N | 1 |
| Zhang, XD | 1 |
| Horton, R | 1 |
| Al-Ahmad, A | 1 |
| Lakkireddy, D | 1 |
| Burkhardt, DJ | 1 |
| Chen, M | 1 |
| Natale, A | 1 |
| Mugnai, G | 1 |
| Paolini, C | 1 |
| Cavedon, S | 1 |
| Mecenero, A | 1 |
| Perrone, C | 1 |
| Bilato, C | 1 |
| Deyell, MW | 1 |
| Steinberg, C | 1 |
| Doucette, S | 1 |
| Parkash, R | 1 |
| Nault, I | 1 |
| Gray, C | 1 |
| Essebag, V | 1 |
| Gardner, M | 1 |
| Sterns, LD | 1 |
| Healey, JS | 1 |
| Hruczkowski, T | 1 |
| Rivard, L | 1 |
| Leong-Sit, P | 2 |
| Nery, PB | 1 |
| Sapp, JL | 1 |
| Dobrev, D | 1 |
| Aguilar, M | 1 |
| Heijman, J | 1 |
| Guichard, JB | 1 |
| Nattel, S | 1 |
| Mourouzis, I | 3 |
| Kostakou, E | 1 |
| Galanopoulos, G | 1 |
| Mantzouratou, P | 1 |
| Pantos, C | 3 |
| Youngquist, ST | 1 |
| Niemann, JT | 1 |
| Shah, AP | 1 |
| Thomas, JL | 1 |
| Rosborough, JP | 1 |
| Kondrat'eva, DS | 1 |
| Afanas'ev, SA | 2 |
| Evtushenko, AV | 1 |
| Shipulin, VM | 1 |
| Popov, SV | 2 |
| Horowitz, JD | 2 |
| Chirkov, YY | 1 |
| Kennedy, JA | 2 |
| Sverdlov, AL | 1 |
| Zeineh, NS | 1 |
| Ayalloore, SG | 1 |
| LeLorier, P | 1 |
| Liyanage, UA | 1 |
| Rajapakse, T | 1 |
| Somaratne, SC | 1 |
| Gunaratne, PS | 1 |
| Bunch, TJ | 1 |
| Mahapatra, S | 1 |
| Murdock, D | 1 |
| Molden, J | 1 |
| Weiss, JP | 1 |
| May, HT | 1 |
| Bair, TL | 1 |
| Mader, KM | 1 |
| Crandall, BG | 1 |
| Day, JD | 1 |
| Osborn, JS | 1 |
| Muhlestein, JB | 1 |
| Lappe, DL | 1 |
| Anderson, JL | 1 |
| Chevalier, P | 1 |
| Timour, Q | 1 |
| Morel, E | 1 |
| Bui-Xuan, B | 1 |
| Heusch, G | 1 |
| Schulz, R | 1 |
| Surber, R | 1 |
| Prochnau, D | 1 |
| Kühnert, H | 1 |
| Figulla, HR | 1 |
| Sharma, H | 1 |
| Sharma, N | 1 |
| Burke, JF | 1 |
| Yan, GX | 1 |
| Kowey, PR | 1 |
| Ermis, C | 1 |
| Zadeii, G | 1 |
| Zhu, AX | 1 |
| Fabian, W | 1 |
| Collins, J | 1 |
| Lurie, KG | 1 |
| Sakaguchi, S | 1 |
| Benditt, DG | 1 |
| Sweeney, MO | 1 |
| Varbiro, G | 1 |
| Toth, A | 1 |
| Tapodi, A | 1 |
| Bognar, Z | 1 |
| Veres, B | 1 |
| Sumegi, B | 1 |
| Gallyas, F | 1 |
| Tsagalou, EP | 2 |
| Anastasiou-Nana, MI | 2 |
| Charitos, CE | 1 |
| Siafakas, CX | 1 |
| Drakos, SG | 1 |
| Ntalianis, A | 1 |
| Terrovitis, JV | 2 |
| Mavrikakis, EM | 1 |
| Doufas, A | 1 |
| Nanas, JN | 2 |
| Rankin, JS | 1 |
| Orozco, RE | 1 |
| Addai, TR | 1 |
| Rodgers, TL | 1 |
| Tuttle, RH | 1 |
| Shaw, LK | 1 |
| Glower, DD | 1 |
| Malliopoulou, V | 2 |
| Paizis, I | 1 |
| Tzeis, S | 2 |
| Moraitis, P | 1 |
| Sfakianoudis, K | 1 |
| Varonos, DD | 1 |
| Cokkinos, DV | 1 |
| Milliez, P | 1 |
| Leenhardt, A | 1 |
| Maisonblanche, P | 1 |
| Vicaut, E | 1 |
| Badilini, F | 1 |
| Siliste, C | 1 |
| Benchetrit, C | 1 |
| Coumel, P | 1 |
| Ugdyzhekova, DS | 1 |
| Antonchenko, IV | 1 |
| Akhmedov, ShD | 1 |
| Singh, BN | 1 |
| Singh, SN | 3 |
| Reda, DJ | 1 |
| Tang, XC | 1 |
| Lopez, B | 1 |
| Harris, CL | 1 |
| Fletcher, RD | 3 |
| Sharma, SC | 1 |
| Atwood, JE | 1 |
| Jacobson, AK | 1 |
| Lewis, HD | 1 |
| Raisch, DW | 1 |
| Ezekowitz, MD | 1 |
| Nanas, SN | 1 |
| Alexopoulos, GP | 1 |
| Kanakakis, J | 1 |
| Oikawa, H | 1 |
| Maesawa, C | 1 |
| Sato, R | 1 |
| Oikawa, K | 1 |
| Yamada, H | 1 |
| Oriso, S | 1 |
| Ono, S | 1 |
| Yashima-Abo, A | 1 |
| Kotani, K | 1 |
| Suzuki, K | 1 |
| Masuda, T | 1 |
| You, B | 1 |
| Pu, J | 1 |
| Liu, N | 1 |
| Yu, R | 1 |
| Ruan, Y | 1 |
| Li, Y | 1 |
| Wang, L | 1 |
| Hagège, AA | 1 |
| Marolleau, JP | 1 |
| Vilquin, JT | 1 |
| Alhéritière, A | 1 |
| Peyrard, S | 1 |
| Duboc, D | 1 |
| Abergel, E | 1 |
| Messas, E | 1 |
| Mousseaux, E | 1 |
| Schwartz, K | 1 |
| Desnos, M | 1 |
| Menasché, P | 1 |
| Fireman, E | 1 |
| Topilsky, I | 1 |
| Viskin, S | 1 |
| Priel, IE | 1 |
| Gula, LJ | 1 |
| Diamantouros, P | 1 |
| Krahn, AD | 1 |
| Skanes, AC | 1 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Mironchik, EV | 1 |
| Dolgosheĭ, TS | 1 |
| Liskovich, TG | 1 |
| Madeshkina, GA | 1 |
| Kokhkovski, AB | 1 |
| Tyshchenko, AD | 1 |
| Marçon, O | 1 |
| Brembilla-Perrot, B | 1 |
| Olshansky, B | 1 |
| Poole, JE | 1 |
| Johnson, G | 1 |
| Anderson, J | 1 |
| Hellkamp, AS | 1 |
| Packer, D | 1 |
| Mark, DB | 1 |
| Lee, KL | 1 |
| Bardy, GH | 1 |
| Tereshchenko, IV | 2 |
| Tsepelev, VV | 2 |
| Molodan, AV | 1 |
| Salgalov, AV | 1 |
| Osaulenko, VV | 1 |
| Materukhin, AN | 1 |
| Leite, SA | 1 |
| Leite, PJ | 1 |
| Rocha, GA | 1 |
| Routledge, PA | 1 |
| Bittencourt, PR | 1 |
| Maron, BJ | 1 |
| Djian, J | 1 |
| Ivanova, ES | 1 |
| Harris, L | 1 |
| Kimura, Y | 1 |
| Shaikh, NA | 1 |
| Politi, A | 1 |
| Galli, M | 1 |
| Ferrari, G | 1 |
| Tisi, G | 1 |
| Baroffio, R | 1 |
| Croce, A | 1 |
| Conti, JB | 1 |
| Curtis, AB | 1 |
| Finance, O | 1 |
| Manning, A | 1 |
| Chatelain, P | 1 |
| Banasiak, W | 2 |
| Pieróg, M | 2 |
| Kokot, K | 1 |
| Fuglewicz, A | 2 |
| Zapałowicz, R | 1 |
| Telichowski, A | 2 |
| Lacheta, W | 1 |
| Molenda, W | 1 |
| Góral, J | 1 |
| Fudalej, L | 1 |
| Pajak, I | 1 |
| Telichowski, C | 1 |
| Galenko-Iarpsjevskii', PA | 1 |
| Lemkina, SM | 1 |
| Kostin, IaV | 1 |
| Neuzner, J | 1 |
| Bahawar, H | 1 |
| Berkowitsch, A | 1 |
| Michel, U | 1 |
| Schlepper, M | 1 |
| Pitschner, HF | 1 |
| Galenko-Iaroshevskiĭ, PA | 1 |
| Melkumova, ER | 1 |
| Bartashevich, VV | 1 |
| Uvarov, AV | 1 |
| Turovaia, AIu | 1 |
| Khankoeva, AI | 1 |
| Galygo, DS | 1 |
| Kennedy, HL | 1 |
| Bobak, J | 1 |
| Telichowska, H | 1 |
| Wiech, K | 1 |
| Kałka, D | 1 |
| Wysota, J | 1 |
| Zebrowska, M | 1 |
| Ponikowski, P | 1 |
| Makita, M | 1 |
| Joh, T | 1 |
| Hayashi, Y | 1 |
| Abe, M | 1 |
| Kazatani, Y | 1 |
| Tatsuno, H | 1 |
| Matsunaka, T | 1 |
| Kubo, M | 1 |
| Kikuchi, S | 1 |
| Connolly, SJ | 1 |
| Yamada, S | 1 |
| Yamaguchi, I | 1 |
| Oral, H | 1 |
| Fisher, SG | 2 |
| Fay, WP | 1 |
| Morady, F | 1 |
| Ong, JJ | 1 |
| Moreau, D | 1 |
| Clauw, F | 1 |
| Martine, L | 1 |
| Grynberg, A | 1 |
| Rochette, L | 1 |
| Demaison, L | 1 |
| Wilhelm, JM | 1 |
| Thannberger, P | 1 |
| Derragui, A | 1 |
| Ruxer, S | 1 |
| Saraceni, O | 1 |
| Kieffer, P | 1 |
| Weston, SN | 1 |
| Weston, CF | 1 |
| Suwa, M | 1 |
| Fogoros, RN | 1 |
| Toft, AD | 1 |
| Boon, NA | 1 |
| Alonso Hernández, P | 1 |
| Otero López, MJ | 1 |
| Calderón Guadilla, RM | 1 |
| Domínguez-Gil Hurlé, A | 1 |
| Micuda, S | 1 |
| Hodac, M | 1 |
| Sispera, L | 1 |
| Parízek, P | 1 |
| Pleskot, M | 1 |
| Zimova, G | 1 |
| Cerman, J | 1 |
| Martínková, J | 1 |
| Pidrman, V | 1 |
| Rochetaing, A | 1 |
| Barbé, C | 1 |
| Kreher, P | 1 |
| Taneda, K | 1 |
| Aizawa, Y | 1 |
| Teo, KK | 1 |
| Mookadam, F | 1 |
| Alboni, P | 1 |
| Delbruyère, M | 1 |
| Cokkinos, DD | 1 |
| Nikitas, N | 1 |
| Carageorgiou, H | 1 |
| Varonos, D | 1 |
| Cokkinos, D | 1 |
| Nisato, D | 1 |
| Bilchick, KC | 1 |
| Fetics, B | 1 |
| Djoukeng, R | 1 |
| Nevo, E | 1 |
| Berger, RD | 1 |
| Mayuga, RD | 1 |
| Singer, DH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Phase IV Multicentric Trial, Comparing the Efficacy and Safety of Radiofrequency Substrate Ablation of Monomorphic Ventricular Tachycardia vs. Antiarrhyhtmic Drugs in Patients Experiencing Appropriate ICD Shocks[NCT03734562] | 180 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
| Association of Postoperative Lactate Levels With Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Graft Surgery[NCT05448521] | 250 participants (Anticipated) | Observational | 2022-08-15 | Recruiting | |||
| Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement - a Randomized Controlled Trial[NCT05076019] | 266 participants (Anticipated) | Interventional | 2022-02-01 | Recruiting | |||
| Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins - Randomized Controlled Trial[NCT05062239] | 100 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | |||
| First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation - a Randomized Study Comparing Early Trigger Isolation Using the Cryoballoon Versus Antiarrhythmic Medication[NCT05939076] | Phase 3 | 220 participants (Anticipated) | Interventional | 2023-08-21 | Not yet recruiting | ||
| Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation[NCT05130268] | Phase 4 | 3,000 participants (Anticipated) | Interventional | 2021-10-29 | Active, not recruiting | ||
| Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation[NCT02145546] | Phase 4 | 600 participants (Anticipated) | Interventional | 2014-05-31 | Not yet recruiting | ||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [NCT00000609] | Phase 3 | 0 participants | Interventional | 1997-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for amiodarone and Heart Disease, Ischemic
| Article | Year |
|---|---|
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Modulation of myocardial metabolism: an emerging therapeutic principle.
Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricula | 2010 |
Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Brain Ischemia; Dronedarone; Humans; Myocardial Ischemi | 2012 |
[Incessant or recurrent ventricular tachycardia. Indications for emergency ablation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Contraindications; | 2012 |
Hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathy, Hypert | 1993 |
[Management of patients with risk of sudden death. The amiodarone example].
Topics: Amiodarone; Arrhythmias, Cardiac; Canada; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Europe; H | 1994 |
Antiarrhythmic therapy in patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Multicenter Studies as Topic; M | 1993 |
[Medical treatment for cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2000 |
Evidence-based medicine and the implantable defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Death, Sudden, Cardiac; Defibrillators, | 1999 |
Thyroid disease and the heart.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Heart Diseases; Humans; Hyperth | 2000 |
Primary prevention in chronic ischemic heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Death, Sudden, Cardiac; Defibrillators, Implant | 2002 |
11 trials available for amiodarone and Heart Disease, Ischemic
| Article | Year |
|---|---|
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2022 |
Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.
Topics: Action Potentials; Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Substitution; F | 2018 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind M | 2005 |
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Cicatrix; Cohort Studies; Combined Modality Th | 2006 |
The role of induced sputum in amiodarone-associated interstitial lung diseases.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Diseases, Interstitial; Male; Myocard | 2007 |
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, | 2008 |
Carbamazepine kinetics in cardiac patients before and during amiodarone.
Topics: Adult; Aged; Amiodarone; Carbamazepine; Chagas Disease; Drug Interactions; Drug Therapy, Combination | 1994 |
[The effect of long term use of amiodarone hydrochloride on time and frequency domain parameters of signal averaged electrocardiogram in patients with ischemia heart disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Administration Schedule; Electrocardiography; Electro | 1997 |
Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biomarkers; Cardiomyopathy, Dilated; Double-Blind Method; | 1999 |
Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A | 2001 |
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; | 1992 |
54 other studies available for amiodarone and Heart Disease, Ischemic
| Article | Year |
|---|---|
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; | 2007 |
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; E | 2011 |
Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Female; Follow-Up Stu | 2021 |
Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Coronary Artery Disease | 2022 |
Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.
Topics: Amiodarone; Animals; Calcium-Binding Proteins; Dronedarone; Hypertrophy, Left Ventricular; Male; Mic | 2013 |
Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Coronary Vessels; Diseas | 2013 |
[Comparative assessment of inotropic reaction of isolated myocardium of patients with ischemic and rheumatic heart disease after short-term periods of rest at the background of amiodarone].
Topics: Amiodarone; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemi | 2008 |
A toxic combination.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Drug Therapy, Combination; Electroc | 2010 |
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc
Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; E | 2011 |
An unusual manifestation of amiodarone toxicity: lung mass mimicking a lung carcinoma.
Topics: Aged; Amiodarone; Biopsy, Fine-Needle; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Myocardial | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Def | 2011 |
Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
Topics: Acute Disease; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Occlusion | 2012 |
Ischemia versus amiodarone induced polymorphic ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differe | 2002 |
Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 2003 |
A bridge, but to where?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 2003 |
Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition.
Topics: Amiodarone; Animals; Apoptosis Inducing Factor; Biological Transport; Disease Models, Animal; Energy | 2003 |
Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Differential Threshold; Electric Counte | 2004 |
Several new considerations in mitral valve repair.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Chordae | 2004 |
Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1.
Topics: Adaptation, Physiological; Amiodarone; Animals; Calcium-Transporting ATPases; Dronedarone; Eating; G | 2005 |
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocard | 2005 |
[Inotropic reactions of myocardium of patients with ischemic heart disease and rats during use of amiodarone].
Topics: Amiodarone; Animals; Disease Models, Animal; Humans; Male; Middle Aged; Myocardial Contraction; Myoc | 2005 |
The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
Topics: Administration, Oral; Aged; Amiodarone; Cardiomyopathy, Dilated; Dobutamine; Female; Hemodynamics; H | 2006 |
Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Humans; Liver Cirrhosis; Male; Myocardi | 2005 |
Effect of lidocaine and amiodarone on transmural heterogeneity of ventricular repolarization in isolated rabbit hearts model of sustained global ischemia.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart V | 2005 |
Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2006 |
[Long QT syndrome induced by cordaron and quinidine].
Topics: Amiodarone; Anemia, Hemolytic; Anti-Arrhythmia Agents; Female; Humans; Hypertension; Long QT Syndrom | 2007 |
[Bi-tachycardia and ischemic cardiopathy (following myocardial infarction)].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Echocardiography; Electrophysiology; Female; Humans | 2007 |
[The effect of kordaron on thyroid function in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Male; Middle Aged; Myocardia | 1995 |
[The preoperative drug correction of disorders in myocardial functional reserve in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Combined Modality Therapy; Coronary Artery Bypass; Drug Therapy, Combination; Hea | 1994 |
[Subclinical hypothyroidism in patients with ischemic heart disease].
Topics: Achilles Tendon; Aged; Amiodarone; Angina, Unstable; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; | 1993 |
Phospholipase inhibition and the electrophysiology of acute ischemia: studies with amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Electrophysiology; Heart; In Vitro Techniques; Lysophospholi | 1993 |
[Pulmonary toxicity due to amiodarone].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Myoc | 1993 |
[Ventricular fibrillation during stress test on a treadmill. Apropos of a case].
Topics: Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Electric Countershock; El | 1993 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
[The effect of intravenously given amiodarone on maintenance of ventricular signal averaged electrocardiogram in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Injections, Intraveno | 1996 |
[Correction with cordarone of changes in cathepsin D induced by simulated circulatory insufficiency and toxic effect of strophanthin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cathepsin D; Male; Myocardial Ischemia; Rats; Strophant | 1996 |
Clinical predictors of defibrillation energy requirements.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Coronary Disease; Defi | 1997 |
[Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Histamine H1 Antagonists; Indoles; Myocardial Inf | 1996 |
Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Multi | 1997 |
[Effective low-dose amiodarone therapy for ventricular tachycardia complicated with ischemic heart disease and poor left ventricular function in an elderly patient].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Myocardial Ischemia; Tachycardia, Ventricula | 1997 |
Implantable cardioverter defibrillators--for whom?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Output, Low; Cause of Death; Coronary Artery Bypass; Dec | 1998 |
Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Disease Pro | 1998 |
Effect of trimetazidine on carnitine palmitoyltransferase-1 in the rat heart.
Topics: Amiodarone; Animals; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; In Vitro Te | 1998 |
Cost-effectiveness of an ineffective therapy(?)
Topics: Amiodarone; Cost-Benefit Analysis; Defibrillators, Implantable; Humans; Meta-Analysis as Topic; Myoc | 1999 |
Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion.
Topics: Adenine Nucleotides; Amiodarone; Animals; Anti-Arrhythmia Agents; Heart; Heart Function Tests; Male; | 1999 |
[Interstitial pneumopathy 2 months after discontinuing treatment with amiodarone].
Topics: Aged; Amiodarone; Humans; Long-Term Care; Lung Diseases, Interstitial; Male; Myocardial Ischemia; Su | 1999 |
The mysterious case of the lost pituitary: amiodarone-induced hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Male; Middle Aged; Myocardial Ischemia; | 2000 |
[Follow-up of thyroid function in patient treated with amiodarone].
Topics: Aged; Amiodarone; Female; Humans; Hypothyroidism; Myocardial Ischemia; Thyroid Function Tests; Vasod | 2000 |
Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circu | 2001 |
Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Circadian Rhythm; Defibrillators, Implantable; Female | 2001 |
[The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillat | 2002 |
Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart.
Topics: Amiodarone; Animals; Dronedarone; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Rats; Rats, | 2002 |
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Comorbidity; Death, | 2002 |
Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Dogs; Elec | 1992 |